PPA, Intangible Asset, Brand & IP Valuation Services Services in China

Purchase Price Allocation (PPA) is a critical accounting and valuation process for M&A in China, governed by CAS 20/IFRS 3. The accurate valuation of intangible assets, particularly brands and IP, is essential for financial compliance and strategic clarity.
COMMERCIAL EXCELLENCE

Loading...

Strategic guidance and institutional-grade solutions customized for your enterprise objectives.

Talk to a Financial Expert

Schedule a complimentary 30-minute discovery call to discuss your enterprise’s financial trajectory.
By submitting, you agree to our Privacy Policy.

Table of Contents

The Mergers and Acquisitions (M&A) environment in the People's Republic of China is characterized by rapid growth, regulatory complexity, and the enormous, often unseen, value locked within intangible assets. For both international investors acquiring Chinese entities and domestic companies expanding through business combinations, navigating the mandatory financial reporting requirements is a paramount challenge. Central to this challenge is the Purchase Price Allocation (PPA), a sophisticated accounting and valuation process that determines the future financial trajectory of the combined entity.In China, PPA is primarily governed by China Accounting Standards (CAS) 20, Business Combinations, which is substantially converged with International Financial Reporting Standards (IFRS 3). This standard demands that the acquirer identifies all assets and liabilities of the target, measures them at their acquisition-date fair values, and records any excess purchase price as goodwill.The valuation of Intangible Assets (IAs), including Brand and Intellectual Property (IP) such as patents, software, and customer relationships, is the most crucial component of a PPA in China. Unlike tangible assets, intangible assets are often not recorded on the target company’s historical balance sheet yet can easily represent the majority of the acquired economic value, particularly in China’s high-tech, consumer goods, and pharmaceutical sectors. A flawed valuation in this area can lead to immediate audit failure, significant future earnings volatility, and a loss of investor trust.

The Imperative of Expert Valuation in China

Compliance and Financial Governance

The strict adherence to CAS 20 (or IFRS 3, if the acquirer is an international firm) is non-negotiable.

  • Accurate Earnings Projection: The fair value assigned to amortizable intangible assets dictates the future amortization expense over their economic useful lives. A higher assigned value means higher expense, directly reducing reported net income and Earnings Per Share (EPS). Aviaan ensures this balance is struck correctly, preventing aggressive amortization charges that can alarm stakeholders.
  • Goodwill Management (CAS 8): Properly identifying and valuing IAs reduces the residual goodwill. Under CAS 8 (Asset Impairment), goodwill must be tested for impairment annually. Minimizing inflated goodwill through rigorous IA valuation minimizes the risk of a material, non-cash impairment charge, a key concern for publicly traded companies in China.
  • Audit Scrutiny: Accounting firms, especially the Big Four, heavily scrutinize the valuation methodologies and assumptions used for PPA in China due to the potential for earnings manipulation. A robust, defensible valuation report is the single greatest tool for navigating this scrutiny efficiently.

Strategic Value and Risk Mitigation

A professional PPA is not just a compliance exercise; it is a vital due diligence and strategy tool.

  • Identifying Core Value Drivers: The valuation process forces management to dissect the purchase price and understand exactly how much was paid for proprietary technology, market access through customer lists, or competitive advantage provided by a strong local brand. This insight is crucial for prioritizing post-merger integration efforts.
  • IP Protection: By assigning significant, verifiable fair values to core IP assets (patents, trade secrets), the acquirer strengthens the legal and commercial justification for future investment in protecting and developing those assets within the Chinese legal framework.
  • Tax Considerations (Where Applicable): While CAS governs financial reporting, a detailed valuation provides a clear breakdown of the transaction value. When dealing with asset acquisitions or hybrid structures, the detailed asset-level valuations provide essential inputs for tax amortization schedules under Chinese tax law, even though the accounting and tax basis often differ.

How Can Aviaan’s Expertise in China’s PPA and Valuation Landscape

Aviaan is positioned as a trusted, objective valuation partner, blending international best practices with deep regulatory and market intelligence specific to the People's Republic of China. Our commitment to delivering audit-defensible and strategically sound PPA reports is built on specialized technical knowledge and comprehensive methodology.

Aviaan’s Comprehensive Valuation Framework for Chinese M&A

Aviaan’s process is a highly detailed, systematic operation covering every aspect of the PPA mandate, ensuring full compliance with CAS 20/IFRS 3 and delivering exceptional strategic clarity.

1. Foundational Analysis and Deal Structuring Review

The process begins with a rigorous review of the transaction documents to establish the correct basis for the PPA. We meticulously analyze the Purchase and Sale Agreement (PSA), legal structure, and all forms of consideration transferred. This includes complex elements often found in high-growth Chinese M&A, such as deferred payments, share-based incentives, and the fair value measurement of contingent consideration (earn-outs) under ASC 820/IFRS 13. Our team applies sophisticated financial modeling (e.g., Monte Carlo simulations) to estimate the acquisition-date fair value of these variable elements, which is critical for establishing the total purchase price pool. We also define the reporting units necessary for future goodwill impairment testing under CAS 8.

2. Tangible Assets and Liability Revaluation

Before tackling intangibles, we ensure the foundation is sound by adjusting all tangible assets and liabilities to fair value. This includes:

  • Net Working Capital: Adjusting items like accounts receivable and inventory to reflect market participant values, including assessments of collectability or obsolescence.
  • Property, Plant, and Equipment (PP&E): We coordinate the appraisal of machinery, equipment, and real estate, utilizing qualified local Chinese appraisers where necessary. The valuation methodologies, typically the Cost Approach (Replacement Cost New Less Depreciation) or Market Approach, are applied meticulously, accounting for local market conditions and age.
  • Assumed Liabilities: Re-measuring all debt, deferred revenue, warranty obligations, and non-cancellable operating leases to their fair value based on current market rates.

3. Specialized Intangible Asset, Brand, and IP Valuation

This is where Aviaan’s expertise truly differentiates us in the Chinese market. We go beyond simple accounting to identify and value the economic substance of the acquired business.

  • Identification of Intangibles: We conduct focused interviews with management, legal, and R&D teams to identify all separately recognizable intangible assets that meet the CAS 20/IFRS 3 criteria (arising from contractual/legal rights or separability). The focus is often on assets like developed technology, in-process R&D (IPR&D), customer relationships, non-compete agreements, and trademarks.
  • Brand and Trademark Valuation: For acquired Chinese brands, Aviaan primarily employs the Relief from Royalty (RFR) Method. This requires sourcing and justifying royalty rates based on comparable licensed brands in the Chinese industry. Our local market intelligence helps calibrate assumptions regarding market penetration, growth potential, and the brand’s protective moat within the PRC, yielding a highly defensible fair value for the brand or trade name, and determining if it qualifies for an indefinite life.
  • Intellectual Property (IP) and Technology Valuation: For assets like patents, proprietary software, and know-how, Aviaan utilizes the Discounted Cash Flow (DCF) method, often implemented as the Multi-Period Excess Earnings Method (MPEEM). MPEEM involves:

    • Forecasting IP-Driven Revenue: Projecting the sales directly attributable to the specific technology.
    • Deducting Contributory Asset Charges: Subtracting a fair return (capital charge) on all other assets required to support the technology (e.g., working capital, fixed assets, assembled workforce).
    • Discounting Excess Earnings: Discounting the residual cash flows (the "excess earnings") back to the valuation date using an appropriate discount rate (WACC adjusted for specific IP risk). This detailed modeling ensures the value attributed to the technology is isolated and robust.

  • Customer-Related Intangibles: For customer relationships and contract backlogs, Aviaan uses MPEEM, focusing on modeling customer attrition rates and projecting revenue streams only from existing customers. Determining a realistic attrition rate—a key point of auditor focus—is achieved through historical analysis and industry benchmarking specific to the Chinese sector.

4. Determination of Economic Useful Lives

A critical component of the valuation is the determination of the economic useful life for each amortizable asset. This lifespan drives the annual amortization expense. Aviaan considers:

  • Legal/Contractual Life: The term of patents, licenses, or non-compete agreements.
  • Economic/Technological Life: The rate of technological obsolescence (especially high in Chinese tech), market demand, and competition.
  • Regulatory/Filing Limitations: Any regulatory restrictions on the asset’s longevity in China.

5. Final Report Generation and Audit Defense

The final output is a comprehensive, technically detailed PPA Valuation Report. This report is structured specifically to meet the documentation requirements of external auditors (both local and international). Aviaan does not just deliver a document; we provide direct, active support, acting as the technical liaison to the client's auditors, defending the methodologies, assumptions, and final fair values, thereby significantly accelerating the audit sign-off process and mitigating client risk.

Aviaan’s Unique Value Proposition in China

Aviaan’s strength lies in its ability to manage cross-border M&A complexity while maintaining local relevance.

  • Global Standards, Local Data: We adhere strictly to the rigorous standards of IFRS/CAS but use local, proprietary market data for discount rates, royalty rates, tax rates, and customer attrition rates, ensuring the valuations are economically sound within the PRC market context.
  • Addressing IPR&D Challenges: Valuing In-Process Research and Development (IPR&D) in China is complex due to the inherent uncertainty. Aviaan’s specialists model IPR&D using a real options approach or a highly risk-adjusted DCF, carefully documenting the stages of completion and technical feasibility to satisfy CAS requirements.
  • Contingency Planning: For transactions involving complex earn-out structures common in China, Aviaan provides ongoing valuation services to re-measure the fair value of contingent consideration at each subsequent reporting period, simplifying the client's quarterly and annual accounting burden.

Case Study: PPA for a Major Chinese Pharmaceutical Acquisition

Client: A European Multinational Pharmaceutical Company (“EuroPharm”) listed on the Frankfurt Stock Exchange (reporting under IFRS).Acquired Entity: A leading Chinese biotech firm (“CNBio”) specializing in oncology pipeline drugs, with significant government grants and clinical trial data.Transaction: Acquisition of 100% of CNBio for €800 Million (approx. RMB 6.2 Billion).Accounting Standard: IFRS 3 (Business Combinations).

The Challenge

The acquired company, CNBio, held minimal tangible assets; its valuation was driven almost entirely by its intangible assets:

  1. Clinical Stage Drug Pipeline (IPR&D): Two core drug candidates in Phase II and Phase III trials.
  2. Proprietary Patient Data: Extensive patient records and clinical trial data collected in China.
  3. Government Licenses & Grants: Favorable regulatory licenses and unspent government research grants.

The key challenge was accurately valuing the high-risk, unproven IPR&D under IFRS 3, a point of immediate contention for EuroPharm’s auditors.

Aviaan’s Solution

Aviaan’s cross-border team executed an IFRS 3 PPA, focusing heavily on the complex biotech intangible assets.

1. Total Consideration: €800 Million (firmly established).

2. Intangible Asset Identification:

  • IPR&D (Drug Candidates): Identified as the highest value driver.
  • Patient Data: Identified as a separately recognizable intangible asset.
  • Regulatory Licenses: Recognized as contractual intangible assets.
  • Assembled Workforce: Not recognized as a separate asset but factored into the goodwill and contributory asset charges.

3. Valuation Methodology and Allocation

  • Risk-Adjusted DCF (rDCF) for IPR&D: Aviaan applied a highly specialized rDCF method. We modeled the full commercial potential of the drugs but applied specific probability of success (POS) factors based on industry-standard clinical trial success rates (e.g., Phase II to Phase III success). This rigorously justified the €450 Million value and was the linchpin of the audit defense.
  • DTL Calculation: We accurately calculated the Deferred Tax Liability (€150M) resulting from the fair value write-ups of the amortizable intangible assets over their tax basis, ensuring full compliance with IFRS (IAS 12/CAS 18)

Conclusion

In China's high-stakes M&A market, the Purchase Price Allocation and the valuation of intangible assets, brands, and IP are not optional accounting chores—they are strategic necessities. Aviaan provides the critical expertise to navigate the complex requirements of CAS 20/IFRS 3. By providing rigorous, audit-defensible valuations for all core assets, including high-value, high-risk items like IPR&D and proprietary technology, Aviaan ensures that acquiring companies meet their regulatory obligations while gaining clear, actionable insight into the true economic value of their acquisition. Partnering with Aviaan guarantees financial integrity and compliance, transforming post-deal complexity into strategic advantage.

Releted posts

PPA, Intangible Asset, Brand & IP Valuation Services services in United States

PPA, Intangible Asset, Brand & IP Valuation Services services in China

PPA, Intangible Asset, Brand & IP Valuation Services services in Germany

PPA, Intangible Asset, Brand & IP Valuation Services services in Japan

PPA, Intangible Asset, Brand & IP Valuation Services services in India

PPA, Intangible Asset, Brand & IP Valuation Services services in United Kingdom

PPA, Intangible Asset, Brand & IP Valuation Services services in France

PPA, Intangible Asset, Brand & IP Valuation Services services in Italy

PPA, Intangible Asset, Brand & IP Valuation Services services in Russia

PPA, Intangible Asset, Brand & IP Valuation Services services in Canada

Talk to an Expert

Schedule a complimentary 30-minute discovery call to discuss your requirements.

By submitting, you agree to our Privacy Policy.

Table of Contents

Need Immediate Help?

Our advisory team is ready to assist you.

Let's Build Your Business Success Together

Our senior partners are available to evaluate your current financial structure and identify opportunities for optimization and risk reduction.

Sector Expertise

Our advisory assignments span a wide range of industries, including:

Healthcare
Hospitality
Restaurants & F&B
Retail
Technology & SaaS
Fintech
Real Estate
Manufacturing
Logistics
Education
Automotive
Consumer Products
Professional Services
Renewable Energy
E-commerce
Beauty & Wellness

Each sector requires different demand drivers, economics, competitive factors and valuation considerations. Our analysis is structured accordingly.

Industries We Serve

Tailored financial strategies for specialized sectors.

Real Estate

Healthcare

Manufacturing

Technology

Retail & E comm

Logistics

Services Offered by Aviaan

Feasibility Study

Independent verification of financial statements to ensure transparency and trust.

Business Plan

A comprehensive analysis to evaluate the commercial, technical, and financial viability of a proposed business or project before investment.

Business Valuation

An objective assessment of a company, asset, or investment to determine its fair market value for transactions, reporting, or strategic decisions.

Due Diligence

A detailed financial review to assess risks, validate performance, and ensure informed decision-making in transactions.

Accounting

End-to-end financial recording, reporting, and compliance services to maintain accurate books and support business decision-making.

Market Research

Launching a new venture, expanding into a new geography, raising capital, or entering a new segment, robust market research is critical.

Need Immediate Help?

Our advisory team is ready to assist you with your urgent financial queries.

Services Offered by Aviaan

Feasibility Study

Independent verification of financial statements to ensure transparency and trust.

LEARN MORE →

Business Plan

A comprehensive analysis to evaluate the commercial, technical, and financial viability of a proposed business or project before investment.

LEARN MORE →

Business Valuation

An objective assessment of a company, asset, or investment to determine its fair market value for transactions, reporting, or strategic decisions.

LEARN MORE →

Due Diligence

A detailed financial review to assess risks, validate performance, and ensure informed decision-making in transactions.

LEARN MORE →

Accounting

End-to-end financial recording, reporting, and compliance services to maintain accurate books and support business decision-making.

LEARN MORE →

Market Research

Launching a new venture, expanding into a new geography, raising capital, or entering a new segment, robust market research is critical.

LEARN MORE →

Ready to Speak with an Expert?

Partner with Aviaan Advisory today to unlock your business’s full potential. Our team of experts is here
to provide tailored solutions and guide you every step of the way.